Cargando…

IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA

PURPOSE: Posterior fossa ependymomas (PFE) are common pediatric brain tumors often assessed with MRI before surgery. Advanced radiomic analysis show promise in stratifying risk and outcome in other pediatric brain tumors. Here, we extracted high-dimensional MRI features to identify prognostic, image...

Descripción completa

Detalles Bibliográficos
Autores principales: Tam, Lydia, Yecies, Derek, Han, Michelle, Toescu, Sebastien, Wright, Jason, Mankad, Kshitij, Ho, Chang, Lober, Robert, Cheshier, Samuel, Vitanza, Nick, Fisher, Paul, Hargrave, Darren, Jacques, Tom, Aquilina, Kristian, Grant, Gerald, Taylor, Michael, Mattonen, Sarah, Ramaswamy, Vijay, Yeom, Kristen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715588/
http://dx.doi.org/10.1093/neuonc/noaa222.348
_version_ 1783618990673756160
author Tam, Lydia
Yecies, Derek
Han, Michelle
Toescu, Sebastien
Wright, Jason
Mankad, Kshitij
Ho, Chang
Lober, Robert
Cheshier, Samuel
Vitanza, Nick
Fisher, Paul
Hargrave, Darren
Jacques, Tom
Aquilina, Kristian
Grant, Gerald
Taylor, Michael
Mattonen, Sarah
Ramaswamy, Vijay
Yeom, Kristen
author_facet Tam, Lydia
Yecies, Derek
Han, Michelle
Toescu, Sebastien
Wright, Jason
Mankad, Kshitij
Ho, Chang
Lober, Robert
Cheshier, Samuel
Vitanza, Nick
Fisher, Paul
Hargrave, Darren
Jacques, Tom
Aquilina, Kristian
Grant, Gerald
Taylor, Michael
Mattonen, Sarah
Ramaswamy, Vijay
Yeom, Kristen
author_sort Tam, Lydia
collection PubMed
description PURPOSE: Posterior fossa ependymomas (PFE) are common pediatric brain tumors often assessed with MRI before surgery. Advanced radiomic analysis show promise in stratifying risk and outcome in other pediatric brain tumors. Here, we extracted high-dimensional MRI features to identify prognostic, image-based, radiomics markers of PFE and compared its performance to clinical variables. METHODS: 93 children from five centers (median age=3.3yrs; 59 males; mean PFS=50mos) were included. Tumor volumes were manually contoured on T1-post contrast and T2-weighted MRI for PyRadiomics feature extraction. Features include first-order statistics, size, shape, and texture metrics calculated on the original, log-sigma, and wavelet transformed images. Progression free survival (PFS) served as outcome. 10-fold cross-validation of a LASSO Cox regression was used to predict PFS. Model performance was analyzed and concordance metric (C) was determined using clinical variable (age at diagnosis and sex) only, radiomics only, and radiomics plus clinical variable. RESULTS: Six radiomic features were selected (all T1): 1 first-order kurtosis (log-sigma) and 5 texture features (3 wavelet, 2 original). This model demonstrated significantly higher performance than a clinical model alone (C: 0.69 vs 0.58, p<0.001). Adding clinical features to the radiomic features didn’t improve prediction (p=0.67). For patients with molecular subtyping (n=48), adding this feature to the clinical plus radiomics models significantly improved performance over clinical features alone (C = 0.79 vs. 0.66, p=0.02). Further validation and model refinement with additional datasets are ongoing. CONCLUSION: Our pilot study shows potential role for MRI-based radiomics and machine learning for PFE risk stratification and as radiographic biomarkers.
format Online
Article
Text
id pubmed-7715588
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77155882020-12-09 IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA Tam, Lydia Yecies, Derek Han, Michelle Toescu, Sebastien Wright, Jason Mankad, Kshitij Ho, Chang Lober, Robert Cheshier, Samuel Vitanza, Nick Fisher, Paul Hargrave, Darren Jacques, Tom Aquilina, Kristian Grant, Gerald Taylor, Michael Mattonen, Sarah Ramaswamy, Vijay Yeom, Kristen Neuro Oncol Imaging PURPOSE: Posterior fossa ependymomas (PFE) are common pediatric brain tumors often assessed with MRI before surgery. Advanced radiomic analysis show promise in stratifying risk and outcome in other pediatric brain tumors. Here, we extracted high-dimensional MRI features to identify prognostic, image-based, radiomics markers of PFE and compared its performance to clinical variables. METHODS: 93 children from five centers (median age=3.3yrs; 59 males; mean PFS=50mos) were included. Tumor volumes were manually contoured on T1-post contrast and T2-weighted MRI for PyRadiomics feature extraction. Features include first-order statistics, size, shape, and texture metrics calculated on the original, log-sigma, and wavelet transformed images. Progression free survival (PFS) served as outcome. 10-fold cross-validation of a LASSO Cox regression was used to predict PFS. Model performance was analyzed and concordance metric (C) was determined using clinical variable (age at diagnosis and sex) only, radiomics only, and radiomics plus clinical variable. RESULTS: Six radiomic features were selected (all T1): 1 first-order kurtosis (log-sigma) and 5 texture features (3 wavelet, 2 original). This model demonstrated significantly higher performance than a clinical model alone (C: 0.69 vs 0.58, p<0.001). Adding clinical features to the radiomic features didn’t improve prediction (p=0.67). For patients with molecular subtyping (n=48), adding this feature to the clinical plus radiomics models significantly improved performance over clinical features alone (C = 0.79 vs. 0.66, p=0.02). Further validation and model refinement with additional datasets are ongoing. CONCLUSION: Our pilot study shows potential role for MRI-based radiomics and machine learning for PFE risk stratification and as radiographic biomarkers. Oxford University Press 2020-12-04 /pmc/articles/PMC7715588/ http://dx.doi.org/10.1093/neuonc/noaa222.348 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Imaging
Tam, Lydia
Yecies, Derek
Han, Michelle
Toescu, Sebastien
Wright, Jason
Mankad, Kshitij
Ho, Chang
Lober, Robert
Cheshier, Samuel
Vitanza, Nick
Fisher, Paul
Hargrave, Darren
Jacques, Tom
Aquilina, Kristian
Grant, Gerald
Taylor, Michael
Mattonen, Sarah
Ramaswamy, Vijay
Yeom, Kristen
IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
title IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
title_full IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
title_fullStr IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
title_full_unstemmed IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
title_short IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
title_sort img-13. mri-based radiomics prognostic markers of posterior fossa ependymoma
topic Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715588/
http://dx.doi.org/10.1093/neuonc/noaa222.348
work_keys_str_mv AT tamlydia img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT yeciesderek img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT hanmichelle img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT toescusebastien img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT wrightjason img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT mankadkshitij img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT hochang img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT loberrobert img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT cheshiersamuel img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT vitanzanick img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT fisherpaul img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT hargravedarren img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT jacquestom img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT aquilinakristian img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT grantgerald img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT taylormichael img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT mattonensarah img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT ramaswamyvijay img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma
AT yeomkristen img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma